Diagnostic News and Research

RSS

Phase 1 clinical trial to test safety and activity of human MAB launched in India

MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.

1 Oct 2009

North Shore-LIJ Health System to implement the largest EHR program in the New York metropolitan area

The North Shore-LIJ Health System announced today it is subsidizing up to 85 percent of the cost of implementing and operating an Electronic Health Records (EHR) system in the offices of its more than 7,000 affiliated physicians in New York City and Long Island -- part of a $400 million investment to strengthen the quality of care throughout the region by automating inpatient and outpatient records in all medical settings, including 13 hospitals.

1 Oct 2009

Researchers develop integrated treatment program for PTSD affected veterans

The wars in Iraq and Afghanistan have resulted in a growing number of soldiers evacuated to the United States for comprehensive care for physical and psychological trauma. Given the number of physical injuries often experienced by soldiers, it is not surprising that chronic pain is a frequent problem among returning soldiers from Operation Iraqi Freedom and Operation Enduring Freedom (OIF/OEF). Common sources of pain are in the head (traumatic-brain injury or post-concussion syndrome), legs (fractures, amputations, burns) and shoulders.

1 Oct 2009

OSI Systems to deliver DexaCare bone densitometers for international customer

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that it has received a contract for approximately $1.3 million from an undisclosed international customer to deliver its DTX-200 DexaCare® bone densitometers.

1 Oct 2009

NCD recommends health care reform for disabled people

The National Council on Disability (NCD) today released a report entitled The Current State of Health Care for People with Disabilities, calling for immediate health care reform for people with disabilities.

1 Oct 2009

UCF research team develops miniature diagnostic tool kit for dementia

With the risk of developing dementia growing at an alarming pace, a University of Central Florida research team is working with the Boston University School of Medicine to develop a miniature diagnostic toolkit in the hopes of stimulating earlier detection and treatment.

1 Oct 2009

Cost-effective screening test for coronary artery disease

A simple, non-invasive test appears to be an effective screening tool for identifying patients with silent heart disease who are at risk for a heart attack or sudden death.

1 Oct 2009

Immunocellular Therapeutics' pilot study can help in early cancer detection

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today results from its pilot study evaluating the cancer detection abilities of one of its lead monoclonal antibody product candidates, ICT-109. Data from this study demonstrated that ICT-109 had a statistically significant ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets.

30 Sep 2009

Flawed legislation puts Ontarians at risk of misdiagnosis and ineffective treatment: CSDMS

The Canadian Society of Diagnostic Medical Sonographers (CSDMS) and the Canadian Association of Registered Diagnostic Ultrasound Professionals (CARDUP) are making a presentation to the Ontario Legislative Assembly Standing Committee on Social Policy studying Bill 179 (the Regulated Health Professions Statute Law Amendment Act, 2009).

30 Sep 2009

SeraCare Life Sciences awarded new contracts for HIV research

SeraCare Life Sciences, Inc. today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been expanded by the NIH to support federally-funded HIV research and testing. These contracts represent a combined $10.8 million in new funding if all options are exercised over the life of the contracts.

30 Sep 2009

SFC Fluidics to develop handheld traumatic brain injury diagnostic device for the U.S. Army

SFC Fluidics, LLC recently announced it has received a contract for approximately $5 million from the Congressionally Directed Medical Research Program for development of a handheld device for rapid diagnosis of traumatic brain injury (TBI). More than 1.5 million Americans suffer head injuries each year, and TBI has become a signature injury for American troops serving in the wars in Iraq and Afghanistan.

30 Sep 2009

New book on written and visual communications for clinicians and laboratory researchers

Strong communication skills are essential for preparing scientific articles, grant proposals, posters, and slide presentations. However, these skills are not commonly taught in schools of public health, medicine, or allied health sciences.

30 Sep 2009

Life Technologies Foundation awards grants for advancements in science

The Life Technologies Foundation, a non-profit arm of Life Technologies Corporation dedicated to advancing science education and scientific discovery, has awarded approximately $1.7 million in new grants that include the creation of an online biology textbook, and building a museum exhibit about the human cell.

30 Sep 2009

Rite Aid and Atlantic General Hospital sign agreement to open Atlantic ImmediCare clinics

Rite Aid Corporation (NYSE:RAD) and Atlantic General Hospital and Health System today announced an agreement to open Atlantic ImmediCare clinics inside three Rite Aid stores in Ocean Pines and Pocomoke City, Maryland, and Millsboro, Delaware, this fall. The clinics, which will be open daily, will provide extended hours for care in the evening and on weekends.

30 Sep 2009

ABL partners with Evivar Medical to develop and commercialize clinical management tools

Advanced Biological Laboratories S.A (ABL) and Evivar Medical Pty Ltd (Evivar) today announced the completion of agreements to cross-licence their respective intellectual property portfolios, and to form strategic alliances based on the use of their proprietary disease management platforms in HIV and Hepatitis B.

30 Sep 2009

Study: Role of genetics and environment in autism spectrum disorders

Researchers at The University of Texas Health Science Center at Houston and the University of the West Indies have joined forces to launch a study of Jamaican children that they hope will unlock the secrets of how genetics and environment may interact to cause autism spectrum disorders.

29 Sep 2009

MabCures develops monoclonal antibodies against Colorectal Cancer

MabCure, Inc., a biotechnology company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has reached another development milestone, with the creation of its MAbs against Colorectal Cancer (CRC). After further characterization the company plans to explore the utility of these MAbs in terms of both the early diagnosis of CRC (in blood or feces specimens), as well as imaging agents for detecting micrometastatic disease during surgery and the detection of cancerous polyps during colonoscopy.

29 Sep 2009

Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today the availability of its ResponseDX: Gastric™ genetic test panel, a proprietary PCR-based diagnostic test. By analyzing the expression of genes that correlate with response to commonly used chemotherapy agents, physicians can better tailor treatment for their patients with gastric cancer and gastroesophageal (GE) junction cancer.

29 Sep 2009

SAIC-Frederick and Roche collaborate on technology advancements in sequencing cancer genes

National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation, and Roche Applied Science, a division of Roche Diagnostics Corporation, have signed a collaboration agreement to assess Roche’s advanced technologies to sequence the genomes of cancer research samples.

From Roche Sequencing and Life Science 29 Sep 2009

New microchip to detect type and severity of cancer

UofT researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment.

29 Sep 2009

Diagnostic News and Research

Phase 1 clinical trial to test safety and activity of human MAB launched in India

North Shore-LIJ Health System to implement the largest EHR program in the New York metropolitan area

Researchers develop integrated treatment program for PTSD affected veterans

OSI Systems to deliver DexaCare bone densitometers for international customer

NCD recommends health care reform for disabled people

UCF research team develops miniature diagnostic tool kit for dementia

Cost-effective screening test for coronary artery disease

Immunocellular Therapeutics' pilot study can help in early cancer detection

Flawed legislation puts Ontarians at risk of misdiagnosis and ineffective treatment: CSDMS

SeraCare Life Sciences awarded new contracts for HIV research

SFC Fluidics to develop handheld traumatic brain injury diagnostic device for the U.S. Army

New book on written and visual communications for clinicians and laboratory researchers

Life Technologies Foundation awards grants for advancements in science

Rite Aid and Atlantic General Hospital sign agreement to open Atlantic ImmediCare clinics

ABL partners with Evivar Medical to develop and commercialize clinical management tools

Study: Role of genetics and environment in autism spectrum disorders

MabCures develops monoclonal antibodies against Colorectal Cancer

Response Genetics launches new genetic diagnostic test for gastric cancer

SAIC-Frederick and Roche collaborate on technology advancements in sequencing cancer genes

New microchip to detect type and severity of cancer

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News